| 000 | 01865 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514032432.0 | ||
| 264 | 0 | _c20021004 | |
| 008 | 200210s 0 0 eng d | ||
| 022 | _a0932-0067 | ||
| 024 | 7 |
_a10.1007/pl00007497 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSendag, F | |
| 245 | 0 | 0 |
_aEffects of sequential combined transdermal and oral hormone replacement therapies on serum lipid and lipoproteins in postmenopausal women. _h[electronic resource] |
| 260 |
_bArchives of gynecology and obstetrics _cJan 2002 |
||
| 300 |
_a38-43 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aApolipoprotein A-I _xblood |
| 650 | 0 | 4 |
_aApolipoproteins B _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xblood |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 |
_aEstradiol _xadministration & dosage |
| 650 | 0 | 4 | _aEstrogen Replacement Therapy |
| 650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFollicle Stimulating Hormone _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLipids _xblood |
| 650 | 0 | 4 |
_aLipoproteins _xblood |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xblood |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNorethindrone _xadministration & dosage |
| 650 | 0 | 4 | _aNorethindrone Acetate |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aKaradadas, N | |
| 700 | 1 | _aOzsener, S | |
| 700 | 1 | _aBilgin, O | |
| 773 | 0 |
_tArchives of gynecology and obstetrics _gvol. 266 _gno. 1 _gp. 38-43 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/pl00007497 _zAvailable from publisher's website |
| 999 |
_c11898037 _d11898037 |
||